GNH USA

USA — NDC

Creon 76000 [USP'U]/1

Creon 76000 [USP'U]/1 is a pancreatic enzyme replacement therapy designed to aid digestion in individuals with exocrine pancreatic insufficiency. This delayed-r

Pancrelipase
Creon
CAPSULE, DELAYED RELEASE PELLETS
76000 [USP'U]/1

Request sourcing

1
Pack/s

What is Pancrelipase?

Creon 76000 [USP'U]/1 is a pancreatic enzyme replacement therapy designed to aid digestion in individuals with exocrine pancreatic insufficiency. This delayed-release capsule contains pancrelipase, helping to break down fats, proteins, and carbohydrates. Ideal for managing digestive health, Creon supports nutrient absorption and overall well-being.

What is Pancrelipase used for?

Creon 76000 [USP'U]/1 is primarily used to treat exocrine pancreatic insufficiency, a condition where the pancreas does not produce enough digestive enzymes. This medication helps to replace the missing enzymes, facilitating the digestion of fats, proteins, and carbohydrates. People with chronic pancreatitis, cystic fibrosis, or those who have undergone pancreatic surgery may benefit from this therapy. Creon is often prescribed to improve digestion and nutrient absorption, addressing symptoms like steatorrhea and malnutrition.

What are the side effects of Pancrelipase?

When taken as directed, Creon 76000 [USP'U]/1 can help improve digestion and reduce symptoms associated with exocrine pancreatic insufficiency. Users may experience better nutrient absorption, leading to improved overall health and well-being. Some individuals might notice a reduction in digestive discomfort and an increase in energy levels. However, individual results can vary, and it's important to follow healthcare provider instructions.

What precautions apply to Pancrelipase?

Creon 76000 [USP'U]/1 should be taken with meals and snacks, and the capsules should not be crushed or chewed. It's important to swallow them whole to ensure the delayed-release mechanism works effectively. Patients with known allergies to pork proteins or any components of the medication should avoid using Creon. Always consult a healthcare provider before starting any new medication, especially if you have pre-existing conditions or are taking other medications.

What does Pancrelipase interact with?

Creon 76000 [USP'U]/1 may interact with certain medications, particularly those that affect stomach acid production. Antacids and proton pump inhibitors can alter the effectiveness of Creon, so it's important to discuss all current medications with a healthcare provider. Additionally, high-fiber diets or certain foods may impact the absorption of the enzymes, so dietary considerations should be taken into account. Always follow healthcare provider advice regarding potential interactions.

Frequently asked questions

What is Creon 76000 [USP'U]/1 used for?+
Creon 76000 [USP'U]/1 is used to treat exocrine pancreatic insufficiency, helping to replace digestive enzymes that the pancreas cannot produce.
How should I take Creon 76000 [USP'U]/1?+
Creon 76000 [USP'U]/1 should be taken with meals and snacks, and the capsules should be swallowed whole without crushing or chewing.
What are the common side effects of Creon 76000 [USP'U]/1?+
Common side effects may include digestive discomfort, bloating, and changes in bowel movements. Always consult a healthcare provider for personalized advice.
Can I take Creon 76000 [USP'U]/1 with other medications?+
Creon 76000 [USP'U]/1 may interact with certain medications, so it's important to discuss all current medications with a healthcare provider.
Is Creon 76000 [USP'U]/1 suitable for everyone?+
Creon 76000 [USP'U]/1 is not suitable for individuals with allergies to pork proteins or any components of the medication. Always consult a healthcare provider before starting.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Pancrelipase
Brand
Creon
Strength
76000 [USP'U]/1
Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Pack size
100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (0032-1224-01)
Manufacturer
AbbVie Inc.
Origin
USA

Related products